UDG Healthcare PLC (LON:UDG) target price held steady at 745.00GBX, issued a report today by Berenberg
- Updated: February 12, 2017
UDG Healthcare PLC (LON:UDG) had its target price hold steady to 745.00GBX by Berenberg in a report released 2/9/2017. The new target price indicates a possible upside of 0.12% based on the company's last stock close price.
Previously on 2/07/2017, Peel Hunt reported about UDG Healthcare PLC (LON:UDG) held steady the target price at 730.00GBX. At the time, this indicated a possible upside of 0.12%.
Yesterday UDG Healthcare PLC (LON:UDG) traded 1.72% higher at 667.00GBX. The company’s 50-day moving average is 658.31GBX and its 200-day moving average is 643.78GBX. The last stock close price is up 5.47% from the 200-day moving average, compared to the S&P 500 which has increased 0.06% over the same time. 1,084,092 shares of the stock were exchanged, up from an average trading volume of 866,235
See Chart Below
UDG Healthcare PLC has a 52 week low of 515.00GBX and a 52 week high of 695.50GBX with a P/E ratio of 8.09 The company’s market cap is currently 0 GBX.
In addition to Berenberg reporting its target price, a total of 6 firms have issued a report on the stock. The consensus target price is 9.00GBX with 1 firm rating the stock a strong buy, 6 firms rating the stock a buy, 1 firm rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell.
About UDG Healthcare PLC (LON:UDG)
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries. The Sharp Packaging Services segment is engaged in contract packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, and also provides Track and Trace serialization services. The Supply Chain Services segment includes Aquilant, a provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.